Evidence map›Paper›PMID 33813735›Full record

ReviewImmunology2021

Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.

S M Touhidul Islam, Jeseong Won, Mushfiquddin Khan, Mark D Mannie, Inderjit Singh

Open access · greenAbstract readReview
In one paragraph

Review in Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Engineering the Immune Response to Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Review
  12. [Mechanisms of 6-Hydroxygen Genistein in the Treatment of Pulmonary Injury in High-Altitude Hypoxic Mice].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. HIF-1 signaling: an emerging mechanism for mitochondrial dynamics.Journal of physiology and biochemistry · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S M Touhidul IslamDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-2720-4102
Jeseong WonDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-2408-0386
Mushfiquddin KhanDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0001-7945-3237
Mark D MannieDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.ORCID 0000-0003-0475-8516
Inderjit SinghDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0003-1013-5569
Medical University of South Carolina · USEast Carolina University · US

Funding

CYTOKINES IN GLIAL CELLS AND EAE BRAINR01NS037766 · NINDS · UNIVERSITY OF NEVADA RENO · PI SINGH, INDERJIT · 1998 to 2019
$5.9M
Neurorestorative Therapy for Stroke InjuryI01RX002090 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI SINGH, INDERJIT · 2016 to 2020
–
BLRD VA I01 BX002829NINDS NIH HHS R01 NS037766RRD VA I01 RX002090
6 · The paper itself

Abstract

Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric (HIF-1α/ HIF-1β) transcription factor in which the oxygen-sensitive HIF-1α subunit regulates gene transcription to mediate adaptive tissue responses to hypoxia. HIF-1 is a key mediator in both regulatory and pathogenic immune responses, because ongoing inflammation in localized tissues causes increased oxygen consumption and consequent hypoxia within the inflammatory lesions. In autoimmune diseases, HIF-1 plays complex and divergent roles within localized inflammatory lesions by orchestrating a critical immune interplay sponsoring the pathogenesis of the disease. In this review, we have summarized the role of HIF-1 in lymphoid and myeloid immunomodulation in autoimmune diseases. HIF-1 drives inflammation by controlling the Th17/T

Indexed as

AnimalsAutoimmune DiseasesCell DifferentiationCellular MicroenvironmentHumansHypoxiaHypoxia-Inducible Factor 1InflammationLymphocytesMyeloid CellsTh17 CellsHypoxia-Inducible Factor 1autoimmune diseasesHIF-1hypoxialymphocytesmyeloid cells

Identifiers

PMID33813735
PMCPMC8358715
OpenAlexW3145278406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.